Teva Pharmaceutical Industries Ltd

Focus Partners Advisor Solutions, LLC TEVA
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/6/2026
Shares
9,587
Value ($000)
325
Weight
0.0%
2024 Q4 - 2026 Q2 (5 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).